Q3 2024 Forward Looking Statements These materials have been prepared for informational purposes only in relation to Zomedica and are not, under any circumstances, to be construed as an offering of any securities for sale directly or indirectly in any province or territory of Canada, in the United States or in the territories or possessions thereof. Prospective investors should not construe the contents of this presentation as legal, tax, financial, investment or other advice. Each investor should make thei ...

Zomedica (ZOM) Q4 2024 Earnings Call March 13, 2025 04:30 PM ET Company Participants Mike Vallie - Managing DirectorLarry Heaton - President & CEOMike Zuehlke - Vice President of Finance & Corporate ControllerScott Jordan - Executive VP of Finance & CFOAndrew Rem - Portfolio Manager Conference Call Participants Robert Leboyer - Senior Biotechnology AnalystRobert Sassoon - Senior Research Analyst Operator Good afternoon, ladies and gentlemen, and welcome to the Zomedica Fourth Quarter twenty twenty four Fina ...